Results 71 to 80 of about 14,486 (179)
Macrophage Activation Syndrome: A Report of Two Cases and a Literature Review
Case Reports in Rheumatology, 2017 Macrophage activation syndrome (MAS) is a severe, potentially fatal condition that may complicate autoimmune diseases, and it belongs to hemophagocytic lymphohistiocytosis (HLH) disorders. MAS occurs in adults and children.
Asaad Alkoht +2 more
doaj +1 more source
Cognitive Behavioral Therapy for Youth With Childhood‐Onset Lupus: A Randomized Clinical Trial
Arthritis Care &Research, Volume 78, Issue 8, Page 1024-1035, August 2026.Objective Our objective was to determine the feasibility and acceptability of the Treatment and Education Approach for Childhood‐Onset Lupus (TEACH), a six‐session cognitive behavioral intervention addressing depressive, fatigue, and pain symptoms, delivered remotely to individual youth with lupus by a trained interventionist.
Natoshia R. Cunningham +29 more
wiley +1 more source
ACR Open Rheumatology, Volume 8, Issue 8, August 2026.Objective Health care transitions are a time of high needs for youth with chronic rheumatic conditions. Our study aimed to evaluate the feasibility of a multicenter randomized‐controlled trial implementing a virtual transition coach intervention (TCI) for youth transitioning from pediatric to adult rheumatology care.
Madison Lackie +6 more
wiley +1 more source
Maternal and infant gut microbiome
iMeta, Volume 5, Issue 4, August 2026.The maternal–infant continuum involves critical windows of host–microbiota co‐adaptation. Preconception, maternal and paternal microbiomes modulate immunity and reproduction. During pregnancy, a gut–placenta axis emerges, where microbial metabolites influence fetal growth or contribute to complications like gestational diabetes mellitus (GDM ...
Huidi Wang +25 more
wiley +1 more source
Juvenile-onset systemic lupus erythematosus in Malay children
Saudi Medical Journal, 2018 [No abstract available].
Ali S, Jawad, Wan Zuraida W A, Hamid
openaire +2 more sources
Revista Brasileira de Reumatologia, 2016 Objective To determine whether there is an association between the profile of cognitive dysfunction and academic outcomes in patients with juvenile systemic lupus erythematosus (JSLE).
Renan Bazuco Frittoli +5 more
doaj +1 more source
Allergy, Volume 81, Issue 8, Page 2744-2774, August 2026.ABSTRACT Hereditary angioedema (HAE) with C1 inhibitor deficiency is a rare disease characterized by unpredictable episodes of tissue swelling (angioedema), which, in most cases, occur first under the age of 18 years, and entail a significant burden of disease not only for the patients but also for their families.
Henriette Farkas +128 more
wiley +1 more source
Педиатрическая фармакология, 2006 Thrombophilia in children with diffuse connective tissue disorders as systemic lupus erythematosus (SLE) and juvenile dermatomyositis (JDM) could arise from various causes including peripherial blood circulation of antiphospholipid antibodies (APH) and ...
O.A. Solntseva
doaj +2 more sources
Macrophage Activation Syndrome as Initial Presentation of Systemic Lupus Erythematosus
Pediatrics and Neonatology, 2008 Macrophage activation syndrome (MAS) is known to be a severe and potentially life-threatening complication of rheumatic disorder, especially systemic juvenile rheumatoid arthritis.
Say-Tin Yeap +5 more
doaj +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 6584-6594, August 2026.ABSTRACT Introduction Type 1 diabetes (T1D) is a chronic autoimmune disease, characterised by progressive destruction of the insulin‐producing pancreatic β‐cells. Preserving remaining β‐cells at the time of diagnosis may improve long‐term outcomes. Frexalimab is a humanised monoclonal antibody specific for CD40L undergoing evaluation for treatment of ...
Andriy Cherkas +11 more
wiley +1 more source